US President Donald Trump's new order poses a challenge to the Indian pharma sector. But there is one pharma company that may ...

India's benchmark indexes are likely to open little changed on Tuesday, after logging their best day in more than four years ...

(Reuters) -Indian pharmaceutical stocks shed 1.3% on Monday, even as the broader markets rose, after U.S. President Donald ...

(Reuters) -Indian pharma stocks fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would ...

Pharma stocks lit up Dalal Street on Tuesday as President Donald Trumps remarks on drug pricing sent mixed signals to global ...

Indian pharmaceutical shares dropped up to 7% following US President Donald Trump's pledge to significantly lower US drug ...

Pharma stocks faced a downturn after US President Donald Trump revealed plans to slash drug prices. Sun Pharmaceuticals and ...

Indian Pharma stocks were on a strong uptrend today, with the Nifty Pharma index rising by 1.19% in intraday trade.

Shares of Indian pharmaceutical companies fell up to 7% after US President Donald Trump promised to sign an executive order ...

US President Trump's move to cut drug prices by 30–80% may severely impact Indian pharma exports and profitability, ...

May 12 (Reuters) - Indian pharma stocks (.NIPHARM), opens new tab fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would cut drug prices by 30%–80% to match ...

Pharma stocks were trading higher on May 13 after better-than-feared Donald Trump’s executive order on pharma last night.